Late-onset sepsis in very preterm infants in Norway in 2009-2018: a population-based study

Zuzana Huncikova; Anlaug Vatne; Hans Jorgen Stensvold; Astri Maria Lang; Ragnhild Støen; Anne Karin Brigtsen; Bodil Salvesen; Knut Asbjørn Alexander Øymar; Arild Rønnestad; Claus Klingenberg; Norwegian Neonatal Network

doi:10.1136/archdischild-2022-324977

Late-onset sepsis in very preterm infants in Norway in 2009-2018: a population-based study

Arch Dis Child Fetal Neonatal Ed. 2023 Sep;108(5):478-484. doi: 10.1136/archdischild-2022-324977. Epub 2023 Feb 2.

Authors

Affiliations

¹ Paediatric Department, Stavanger University Hospital, Stavanger, Norway.
² Department of Clinical Science, University of Bergen, Bergen, Hordaland, Norway.
³ Neonatal Department, Oslo University Hospital Rikshospitalet, Oslo, Norway.
⁴ Faculty of Medicine, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
⁵ Paediatric Department, Akershus University Hospital, Lorenskog, Norway.
⁶ Department of Paediatrics, St. Olav University Hospital, Trondheim, Norway.
⁷ Department of Neonatal Intensive Care, Oslo University Hospital Ullevaal, Oslo, Norway.
⁸ Department of Paediatrics and Adolescents Medicine, Haukeland University Hospital, Bergen, Norway.
⁹ Department of Paediatrics, University Hospital of North Norway, Tromso, Norway claus.klingenberg@unn.no.
¹⁰ Faculty of Health Sciences, University of Tromsø, Tromsø, Norway.

Abstract

Objective: To evaluate epidemiology and outcomes among very preterm infants (<32 weeks' gestation) with culture-positive and culture-negative late-onset sepsis (LOS).

Design: Cohort study using a nationwide, population-based registry.

Setting: 21 neonatal units in Norway.

Participants: All very preterm infants born 1 January 2009-31 December 2018 and admitted to a neonatal unit.

Main outcome measures: Incidences, pathogen distribution, LOS-attributable mortality and associated morbidity at discharge.

Results: Among 5296 very preterm infants, we identified 582 culture-positive LOS episodes in 493 infants (incidence 9.3%) and 282 culture-negative LOS episodes in 282 infants (incidence 5.3%). Extremely preterm infants (<28 weeks' gestation) had highest incidences of culture-positive (21.6%) and culture-negative (11.1%) LOS. The major causative pathogens were coagulase-negative staphylococci (49%), Staphylococcus aureus (15%), group B streptococci (10%) and Escherichia coli (8%). We observed increased odds of severe bronchopulmonary dysplasia (BPD) associated with both culture-positive (adjusted OR (aOR) 1.7; 95% CI 1.3 to 2.2) and culture-negative (aOR 1.6; 95% CI 1.3 to 2.6) LOS. Only culture-positive LOS was associated with increased odds of cystic periventricular leukomalacia (cPVL) (aOR 2.2; 95% CI 1.4 to 3.4) and severe retinopathy of prematurity (ROP) (aOR 1.8; 95% CI 1.2 to 2.8). Culture-positive LOS-attributable mortality was 6.3%, higher in Gram-negative (15.8%) compared with Gram-positive (4.1%) LOS, p=0.009. Among extremely preterm infants, survival rates increased from 75.2% in 2009-2013 to 81.0% in 2014-2018, p=0.005. In the same period culture-positive LOS rates increased from 17.1% to 25.6%, p<0.001.

Conclusions: LOS contributes to a significant burden of disease in very preterm infants and is associated with increased odds of severe BPD, cPVL and severe ROP.

Keywords: Intensive Care Units, Neonatal; Microbiology; Neonatology; Sepsis.

MeSH terms

Bronchopulmonary Dysplasia* / epidemiology
Cohort Studies
Female
Fetal Growth Retardation
Gestational Age
Humans
Infant
Infant, Extremely Premature
Infant, Newborn
Infant, Premature, Diseases* / epidemiology
Intensive Care Units, Neonatal
Leukomalacia, Periventricular* / epidemiology
Retinopathy of Prematurity* / epidemiology
Sepsis* / epidemiology